Box score
Outlook Therapeutics, Inc.
Reported $60M sold in a new Form D filed March 29, 2024 (Iselin, New Jersey).
- Biggest raise
- $60M filed Mar 29, 2024
- League
- Bio & Health Biotechnology
- Based in
- Iselin, New Jersey
- Season rank
- #84 of 1,389 in the Bio & Health League; #329 of 12,443 overall (2024)
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-05-07 | New notice not ranked | $0 | $5M | SEC |
| 2025-01-27 | New notice not ranked | $0 | $32M | SEC |
| 2024-04-16 | New notice | $5M | $13.3M | SEC |
| 2024-03-29 | New notice | $60M | $159M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1649989.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Navigator Medicines, Inc. rookie | Bio & Health | $50M |
| 2 | Interpace Biosciences, Inc. | Bio & Health | $47M |
| 3 | ChemoMouthpiece, LLC rookie | Bio & Health | $10M |
| 4 | Imunon, Inc. | Bio & Health | $10M |
| 5 | Neurock Pharmaceuticals Inc. rookie | Bio & Health | $10M |
| 6 | Claris Biotherapeutics, Inc. | Bio & Health | $10M |